Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

In vitro results show potency of novel bispecific HIV-1-neutralizing antibody

March 13, 2012

Dendritic cell-based vaccine is safe in patients with HIV

March 12, 2012

Recombinant protein therapy active against HIV in phase II trial

March 9, 2012

Gene-modified stem cell therapy shows promise to combat HIV infection

March 9, 2012

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

March 8, 2012

Bristol-Myers Squibb divulges new products to treat HIV infection

March 6, 2012

Galen acquires chemotherapy agent from Gilead

Feb. 27, 2012

Scripps Research Institute receives funds to develop new HIV inhibitors

Feb. 27, 2012

Canadian distribution agreement set for tesamorelin

Feb. 22, 2012

Bionor provides update on development of HIV vaccine

Feb. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...